YD Bio Limited Ordinary Shares
YDES · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,132 | $87 | $14 | $5 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $263 | $98 | $18 | $0 |
| Inventory | $37 | $69 | $0 | $0 |
| Other Curr. Assets | $35 | $17 | $171 | $124 |
| Total Curr. Assets | $3,468 | $272 | $203 | $130 |
| Property Plant & Equip (Net) | $88 | $14 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2,680 | $0 | $0 | $0 |
| Long-Term Investments | $10,532 | $11 | $17,731 | $117,932 |
| Tax Assets | $0 | $25 | $0 | $0 |
| Other NC Assets | -$9,904 | $0 | $0 | $0 |
| Total NC Assets | $3,396 | $49 | $17,731 | $117,932 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,864 | $321 | $17,934 | $118,061 |
| Liabilities | – | – | – | – |
| Payables | $27 | $18 | $0 | $0 |
| Short-Term Debt | $17 | $48 | $0 | $0 |
| Tax Payable | $0 | $2 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $219 | $231 | $5,551 | $1,997 |
| Total Curr. Liab. | $263 | $298 | $5,551 | $1,997 |
| LT Debt | $6 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $2,200 | $1,185 | $7,108 |
| Total NC Liab. | $11 | $2,200 | $1,185 | $7,108 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $22 | $13 | $0 | $0 |
| Total Liabilities | $274 | $298 | $6,735 | $9,105 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $144 | $105 | $17,730 | $115,000 |
| Retained Earnings | -$1,927 | -$515 | -$6,532 | -$6,520 |
| AOCI | $45 | $47 | $0 | $0 |
| Other Equity | $8,328 | $386 | $0 | $476 |
| Total Equity | $6,590 | $23 | $11,198 | $108,956 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,864 | $321 | $17,934 | $118,061 |
| Net Debt | -$3,110 | -$40 | -$14 | -$5 |